Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)

Historical Holders from Q2 2019 to Q3 2025

Symbol: STOK on Nasdaq
Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 54,711,345
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 67,696,992
Holdings value: $1,574,192,573
% of all portfolios: 0.015%
Number of holders: 149
Number of buys: 81
Number of sells: -62
Average buys %: +0%
Average sells %: -0.01%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
FMR LLC	12.5%	-7.9%	$161,328,840	-$12,876,238	6,865,057	-7.4%	FMR LLC	30 Sep 2025
RTW INVESTMENTS, LP	9.99%		$50,498,414		5,310,033		RTW Investments, LP	31 Dec 2024
Redmile Group, LLC	8%		$52,554,931		4,375,931		Redmile Group, LLC	30 Jun 2025
BlackRock, Inc.	6.8%	+16.7%	$87,769,558	+$14,428,761	3,732,540	+19.7%	BlackRock, Inc.	30 Sep 2025
MORGAN STANLEY	6.5%		$32,588,288		3,426,739		Morgan Stanley	31 Dec 2024
TORONTO DOMINION BANK	5.8%		$74,571,563		3,173,258		The Toronto-Dominion Bank	30 Sep 2025
BlackRock Portfolio Management LLC	4.7%	-8%	$28,946,115	-$2,192,358	2,550,341	-7%	BlackRock Portfolio Management LLC	30 Jun 2025
Skorpios Trust	4.1%	-31.7%	$29,037,049	-$12,870,000	2,256,181	-30.7%	Montrago Trustees Ltd	22 Aug 2025

Institutional Holders of Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	67,696,992	$1,574,192,573	+$64,455,944	$2,361,750	$13,162,350	$23.5	149
2025 Q2	65,548,147	$743,993,162	+$30,166,679	$644,680	$0	$11.35	133
2025 Q1	63,384,229	$421,575,155	+$30,343,505	$940,975	$19,285	$6.65	124
2024 Q4	58,062,255	$640,428,361	-$5,638,079	$262,514	$33,090	$11.03	129
2024 Q3	58,214,468	$715,466,637	-$45,762,031	$425,234	$81,114	$12.29	116
2024 Q2	61,301,002	$828,175,296	+$96,412,204	$110,782	$152,663	$13.51	114
2024 Q1	54,138,461	$730,867,238	+$123,726,512	$1,490,400	$815,050	$13.5	101
2023 Q4	45,032,645	$236,869,874	+$6,784,370	$4,156	$4,734	$5.26	81
2023 Q3	43,943,299	$173,133,829	-$18,481,683	$17,336	$44,128	$3.94	96
2023 Q2	46,534,137	$494,657,865	+$21,008,744	$160,513	$2,878,604	$10.63	98
2023 Q1	44,636,031	$371,816,808	+$35,289,257	$14,161	$98,294	$8.33	97
2022 Q4	40,284,847	$371,831,189	-$22,554,117	$40,612	$140,296	$9.23	106
2022 Q3	42,272,703	$544,351,939	-$11,748,534	$5,567,000	$0	$12.84	99
2022 Q2	43,072,954	$569,403,611	+$19,595,358		$514,000	$13.21	88
2022 Q1	41,334,322	$870,301,369	+$123,934,287		$3,323,000	$21.05	96
2021 Q4	35,383,061	$848,561,802	+$26,332,046	$0	$0	$23.99	91
2021 Q3	19,355,184	$492,398,465	-$30,803,526	$745,000	$336,000	$25.44	89
2021 Q2	20,216,239	$680,314,450	-$703,085,149	$1,087,000	$1,721,000	$33.66	96
2021 Q1	38,422,385	$1,492,282,987	-$15,747,693	$3,962,000	$2,755,000	$38.84	104
2020 Q4	38,644,696	$2,393,196,414	+$252,468,837	$501,000	$4,418,000	$61.93	93
2020 Q3	34,632,372	$1,159,842,494	+$2,937,942		$1,403,000	$33.49	89
2020 Q2	34,945,268	$824,517,432	+$9,797,711		$341,000	$23.83	70
2020 Q1	34,562,212	$791,472,895	+$23,374,012			$22.9	67
2019 Q4	33,483,529	$948,191,901	+$22,388,802			$28.32	64
2019 Q3	15,935,472	$338,961,585	+$30,078,348			$21.49	52
2019 Q2	14,232,528	$409,341,450	+$409,341,450			$29.17	47